| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3256786 | Clinical Immunology | 2016 | 8 Pages |
•The prevalence of ILC2s in nasal polyps was high in patients with ECRS.•The prevalence of ILC2s in blood was not different between ECRS and non-ECRS.•The prevalence of ILC2s in blood was high in patients with allergic rhinitis.•The prevalence of ILC2s in blood was low in patients with asthma.•Alternaria-induced IL-33 secretion was increased in nasal epithelial cells of ECRS.
ILC2s represent a critical innate cellular source of type 2 cytokines and may play important roles in various diseases. We examined the role of ILC2s in the pathogenesis of two subgroups of CRSwNP: ECRS and non-ECRS. We analyzed the prevalence of ILC2s in sinonasal tissues and in blood from patients with ECRS, non-ECRS, CRSsNP, and control. The prevalence of ILC2s in nasal tissues was higher in patients with ECRS as compared to those with non-ECRS or CRSsNP. The prevalence of blood ILC2s was not different between patients with ECRS and non-ECRS. The prevalence of blood ILC2s was higher in patients with allergic rhinitis and elevated serum IgE levels. Alternaria-induced IL-33 secretion was increased in nasal epithelial cells derived from patients with ECRS as compared to those from patients with non-ECRS or CRSsNP. ILC2s may be involved in the pathogenesis of CRSwNP, in particular in patients with tissue eosinophilia (i.e., ECRS).
